Introduction
The prevalence of 24-h ambulatory blood pressure and home blood pressure monitoring has made it easy to investigate the predictive role of multiple blood pressure values outside of the clinic setting (1) (2) (3) . Morning rise in blood pressure (4) (5) (6) and high morning blood pressure itself (7-9) have been noted as predictors of hypertensive target organ damage. Previous studies have been population-based studies (5, 8) or mass (LVM) in a homogenous population who were treated with a long-acting calcium channel blocker, amlodipine.
Methods

Subjects and Study Design
This study was conducted on 297 Japanese subjects (188 men and 109 women; mean age, 62.8 years; range, 36 to 90 years) with moderate, established primary hypertension who were treated with amlodipine monotherapy over 1 year (mean dose, 5.5 2.3 mg/day; range, 2.5 to 10 mg/day). Subjects with a secondary form of hypertension, with diabetes mellitus, as diagnosed according to the glucose criteria of the World Health Organization (WHO) Consultation (fasting plasma glucose levels 7.0 mmol/l, 2-h after glucose load 11.1 mmol/l) (10), renal failure (serum creatinine level 133 µmol/l), or severe liver dysfunction (serum transaminase 100 IU/l) were excluded from this study. Clinical information about the subjects was obtained from their medical records, and included the duration of hypertension and antihypertensive medication, family history of hypertension, daily alcohol intake, and smoking habits. The estimated duration of hypertension and antihypertensive medication were 13.0 10.1 years (range: 2 to 50 years) and 7.7 7.8 years (range: 1 to 47 years), respectively. Two hundred thirty subjects (77.4%) had a family history of hypertension. One hundred eighty subjects (60.6%) took alcohol every day and 65 subjects (21.8%) were current smokers. Subjects included in the study underwent home blood pressure measurements for 3 months and routine clinical evaluation, including biochemical measurements and cardiac echocardiography (detailed below). The nature of the study and potential risk associated with it were explained to all subjects, who gave their informed consent before participating in the study. The study protocol was approved by the Institutional Review Board on Human Investigations of NTT Kanto Medical Center.
Measurement of Blood Pressures
Office blood pressure and pulse rate were measured by averaging the last 2 of 3 readings taken by nursing staff with an Omron office digital blood pressure monitor (HEM-907; Omron Health Care, Tokyo, Japan) (11) in the morning (time of measurements, 10:36 0:49; range, 9:10-11:56) with subjects in the sitting position on monthly outpatient clinic visits. Blood pressure values used for analysis were the average of data obtained over 3 months. Subjects were instructed on how to measure their own blood pressures at home by nursing staff members according to the Japanese Society of Hypertension guidelines for self-monitoring of blood pressure at home (12) . The monitor used in this study was a cuffoscillometric device (Omron HEM-737 IntelliSense; Omron Health Care), which was reported to satisfy the Association for the Advancement of Medical Instrumentation's criteria for a general adult population across large ranges of age, blood pressure, body mass, and cuff circumference (13) . Each device was checked by connecting to the sphygmomanometer with a Y-connector before use. Subjects were requested to do a series of 2 consecutive measurements in a seated position in the morning on awakening before breakfast and amlodipine intake (time of measurements, 7:28 1:03; range, 4:58-10:31), and then two additional measurements in a seated position in the evening at bedtime (time of measurements, 22:15 1:10; range, 17:10-1:31), and to write their measurement results in a booklet for 3 months. The blood pressure and pulse rate values used for analysis were the average of daily data only when measurements were done both in the morning and in the evening.
Echocardiography
Echocardiograms were recorded with a SONOS 5500 Ultrasound Imaging System (Philips Medical Systems, Tokyo, Japan) equipped with a 2.0-to 4.0-MHz transducer. Echocardiographic examinations were performed by a trained physician who was unaware of patients' clinical data.
Two-dimensional guided M-mode echocardiograms of the left ventricle were taken at or just below the mitral valve with the patient in the partial left lateral decubitus position, and 3 measurements were averaged. End-systolic and enddiastolic measurements of LV internal dimension, interventricular septal thickness, and LV posterior wall thickness were made according to the American Society of Echocardiography recommendations (14) . LVM was calculated using the following formula introduced by Devereux et al. (15) on the basis of necropsy validation studies: nal diameter) (16) . Only patients whose echocardiograms were of adequate quality for performing M-mode measurements of LVM were included in this study. Individuals with more than trivial mitral or aortic regurgitation detected by Doppler-echocardiography were excluded from the study in order to eliminate the effect of valvular regurgitation on LVM (17) .
Biochemical Measurements
Blood samples for biochemical measurements were drawn after fasting over 12-h. Serum total protein, creatinine, cholesterol and triglycerides were measured by an enzymatic technique with an automatic analyzer (Model H 736; Hitachi, Tokyo, Japan). Serum high density lipoprotein (HDL) cholesterol was measured after precipitation of low density lipoprotein, very low density lipoprotein, and chylomicron with dextran sulfate, magnesium chloride and polyethylene glycol. Plasma glucose was measured by the glucokinase method on an automatic analyzer. Glycated HbA1c was measured by high performance liquid chromatography. The serum level of insulin was determined by competitive enzyme immunoassay with a double antibody procedure using EIA Test Insulin II [BMY] (Boehringer Mannheim, Mannheim, Germany). The homeostasis model assessment insulin resistance index (HOMA-IR) was calculated by the formula: glucose (mmol/l) insulin ( µU/ml)/22.5, and used as an index of insulin resistance (18) .
Statistical Analysis
The software package SPSS 12.0J for Windows (SPSSInc., Chicago, USA) was used for the statistical analysis. Data are expressed as the mean SD. Intergroup comparisons were performed using one-way analysis of variance (ANOVA) and the χ 2 test (continuous and categorical variables, respectively). When ANOVA showed an overall significance, Fisher's protected least significance difference was used for intergroup comparisons. Analysis of covariates was used to adjust the LVMI in each group for 8 covariates: age, gender (1: men; 2: women), dose of amlodipine, alcohol consumption, body mass index (BMI), office systolic blood pressure (SBP), and morning and evening home SBP (HSBP)
Results
Control of Blood Pressure by Home Blood Pressure Monitoring
The relationship between morning and evening HSBP in the 297 patients is shown in Fig. 1 . They were classified into the following 4 groups: 174 cases (58.6%) of good control with both morning and evening HSBP <135 mmHg; 57 cases (19.2%) of morning hypertension with morning HSBP 135 mmHg and evening HSBP <135 mmHg; 3 cases (1.0%) of evening hypertension with morning HSBP <135 mmHg and evening HSBP 135 mmHg; and 63 cases (21.2%) of poor control with both morning and evening HSBP 135 mmHg. Only 3 subjects were classified as having evening hypertension, and they were excluded from further analysis in the present study because of the small size of this group.
Biochemical and Echocardiographic Characteristics in Grouping According to Home Blood Pressure
The morning hypertension group had a higher BMI, longer duration of use of antihypertensive medication, higher rate of alcohol consumption, and higher dose of amlodipine used compared to the good control group. They also had significantly higher echocardiographic measurements, such as LV internal dimension, interventricular septal thickness, LV posterior wall thickness, and LVMI. Serum insulin was also significantly higher in the morning hypertension group than in the good control group without a corresponding change of plasma glucose or HbA1c, which resulted in an increase in HOMA-IR, indicating increased insulin resistance. These clinical, metabolic and echocardiographic parameters in the morning hypertension group were identical on the whole to those in the poor control group (Table 1) . The increases in LVMI in the morning hypertension and poor control groups were significant after adjustment for age, gender, dose of amlodipine, alcohol consumption, BMI, office SBP, and morning and evening HSBP (Fig. 2) .
Relationship between LVMI and the Difference between Morning and Evening Blood Pressure
In order to investigate the relationship between the grade of morning rise in blood pressure and various parameters, 294 subjects were classified into 5 groups according to the difference between morning and evening HSBP (∆HSBP), a group in which ∆HSBP was 5 to less than 5 mmHg (< 5 mmHg group, n 150), a group with ∆HSBP of 5 to less than 10 mmHg ( 5 mmHg group, n 71), a group with ∆HSBP of 10 to less than 15 mmHg ( 10 mmHg group, n 35), a group with ∆HSBP of 15 to less than 20 mmHg ( 15 mmHg group, n 24), and a group with ∆HSBP of 20 mmHg or more ( 20 mmHg group, n 14). There were no significant differences in LVMI between the < 5 mmHg and 5 mmHg groups, while LVMI increased in the group with a ∆SBP over 10 mmHg. The increase in LVMI in this group was associated with an increase in HOMA-IR (Table  2) , and was still significant after adjustment for age, gender, 
<0.001
Values are mean SD. p<0.05 vs. < 5 mmHg group. SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment insulin resistance index; LV, left ventricular. dose of amlodipine, alcohol consumption, BMI, office SBP, and morning and evening HSBP (Fig. 3) . Table 3 shows the univariate correlation between LVMI and several clinical variables. The strongest correlation was found for ∆HSBP (r 0.602, p<0.001). Other factors with significant correlation were age, dose of amlodipine used, alcohol consumption, insulin, HOMA-IR, and several office and home blood pressure variables (Table 3) . In a stepwise multivariate regression analysis, ∆HSBP, morning HSBP, HOMA-IR and age were determined to be significant contributing factors for LVMI. This regression model could explain 44.1% of LVMI variability (Table 4) .
Contributing Factors for LVM
Discussion
In this study, LVMI was increased in subjects with morning hypertension or with morning rise in blood pressure, even after adjusting for several confounding factors. The morning rise in blood pressure represented 36.2% of the total variance of LVMI, and all the remaining factors, including morning HSBP, HOMA-IR and age, represented only 7.9% of the variance. Morning rise in blood pressure (4-6) and high morning blood pressure itself (7-9) have been noted as predictors of hypertensive target organ damage, but these previous studies were mainly population-based studies (5, 8) or cross-sectional studies in untreated hypertensive patients (4, 7, 9) . A population-based study in Ohasama showed that subjects with morning HSBP over 138 mmHg had a high relative risk for cardiovascular events compared to normotensive subjects (8) . Furthermore, it has been reported that the relative risk hazard for cardiovascular mortality, as determined by a greater than 10 mmHg difference in diastolic blood pressure (DBP) values between the morning and evening, was increased in 1,281 untreated hypertensive subjects aged 40 years and over (5). Gosse et al. observed that SBP on arising was significantly and independently correlated with LVM in untreated hypertensive patients (7), and in a subsequent study, SBP on arising had a prognostic value for cardiovascular events during a follow-up of over 5 years (9). Kuwajima et al. (4) found that the increase in SBP after getting up was significantly correlated with LVMI in elderly hypertensive patients, but they did not mention any correlation between SBP after getting up and LVMI or any relationship between LVMI and antihypertensive medications. A prospective study by Kario et al. (6) demonstrated that subjects with a morning surge of SBP had a higher baseline prevalence of cerebral infarcts by brain magnetic resonance imaging and a higher stroke incidence during the follow-up period of 41 months. However, they provided insufficient information about antihypertensive medication during the follow-up periods. Because antihypertensive drugs may differ in their ability to reduce LVM (19, 20) , it is considered desirable to study the relationship between morning blood pressure and LVMI in a homogeneous population. Subjects who were treated with a long-acting calcium channel blocker, amlodipine, were selected for this study. Amlodipine has a distinct pharmacokinetic profile with a long elimination half life of 34-h which enables steady-state plasma concentrations to be achieved by once-daily dosing (21) . The present study confirmed the important role of a morning rise in blood pressure for predicting LVMI in homogeneously treated hypertensive patients. Another important finding of the present study was the influence of insulin resistance on the level of LVMI. HOMA-IR was related significantly with LVMI and was selected as one of the significant predictive factors for LVMI by stepwise regression analysis. The relationship between insulin sensitivity and LV hypertrophy has been shown in population based studies (22, 23) and cross-sectional studies employing untreated hypertensive patients (24) (25) (26) (27) . Two population-based studies confirmed that plasma insulin or HOMA-IR were predictors of LV hypertrophy independent- (26) observed that a significant relationship between LVMI and insulin sensitivity index determined from frequently sampled intravenous glucose tolerance tests remained after adjustment for the influence of BMI and blood pressure. Verdecchia et al. (27) confirmed that HOMA-IR, BMI and 24-h SBP and DBP were associated with LVMI. Our data are in accordance with these reports even in treated hypertensive patients. It will be necessary to perform further clinical studies by glucose clamp in order to clarify the relationship between insulin resistance and LVMI in relation with antihypertensive drug treatments.
In conclusion, our observation indicates that a morning rise in SBP of over 10 mmHg compared to evening SBP is a strong predictor of cardiac hypertrophy independently of age, insulin resistance and morning hypertension. 
